Showing results (371-380 of 522) with videos related to

Sort By:
Pageof 53
Clinical Therapeutics|July 18, 2003
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulationsJane P Barrett, Katerina A Vardulaki, Christopher Conlon, et al.
Bone Marrow Transplantation|November 3, 2015
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisM L Riches, S Trifilio, M Chen, et al.
Ejhaem|July 18, 2022
Immune reconstitution following umbilical cord blood transplantation: IRES, a study of UK paediatric patientsJohn Girdlestone, Meera Raymond, Bronwen Shaw, et al.
British Journal of Haematology|July 11, 2006
The clinical outcome and toxicity of high-dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British Society of Blood and Marrow Transplantation studyJennifer M Bird, Rhian Fuge, Bhawna Sirohi, et al.
Bone Marrow Transplantation|June 22, 2005
Early emergence of PNH-like T cells after allogeneic stem cell transplants utilising CAMPATH-1H for T cell depletionR J Garland, S J Groves, P Diamanti, et al.
American Journal of Hematology|July 29, 2016
Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXIIAnita J Kumar, Phyllis A Gimotty, Joel M Gelfand, et al.
The Lancet. Haematology|March 31, 2022
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trialDavid I Marks, Laura Clifton-Hadley, Mhairi Copland, et al.
Haematologica|November 28, 2015
Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donorsEsteban Arrieta-Bolaños, Neema P Mayor, Steven G E Marsh, et al.
Cancer|November 24, 2020
Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemiaWendy Stock, Giovanni Martinelli, Matthias Stelljes, et al.
British Journal of Haematology|May 27, 2005
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Bronwen Shaw, Simona Iacobelli, et al.
Pageof 53